Cadila Healthcare Ltd (CADILAHC) - Financial and Strategic SWOT Analysis Review
Cadila Healthcare Ltd (CADILAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Cadila Healthcare Ltd (Zydus Cadila) is an integrated global healthcare provider. It discovers, develops, manufactures and commercializes various healthcare products. The company’s product portfolio includes active pharmaceutical ingredients (APIs), formulations, wellness and animal health products. Zydus Cadila’s products find application in the treatment of diseases in the therapeutic areas of gastrointestinal, cardiovascular, respiratory, pain management, cancer, inflammation, neurology, and women's health, among others. It conducts research to develop biologics, biosimilars, vaccines and new chemical entities. The company has manufacturing facilities in Gujarat, Goa, Maharashtra, Sikkim and Himachal Pradeshin India; Brazil and the US. It has presence in the US, Europe, South Africa, Japan, Brazil, and other emerging markets. Zydus Cadila is headquartered in Ahmedabad, Gujarat, India.
Cadila Healthcare Ltd Key Recent Developments
Jun 07,2021: Serum Institute obtains DCGI nod to produce Sputnik V vaccine in India
May 31,2021: Zydus Cadila fights counterfeit drugs with new packaging feature
May 28,2021: Zydus Cadila files for DCGI approval to study Covid-19 drug in India
May 10,2021: Zydus Wellness’ consolidated Q4 Net Profit up by 92.7% at Rs. 1331 million
Feb 05,2021: Zydus Cadila’s Net Profit up by 41% in Q3 FY21
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Cadila Healthcare Ltd (Zydus Cadila) is an integrated global healthcare provider. It discovers, develops, manufactures and commercializes various healthcare products. The company’s product portfolio includes active pharmaceutical ingredients (APIs), formulations, wellness and animal health products. Zydus Cadila’s products find application in the treatment of diseases in the therapeutic areas of gastrointestinal, cardiovascular, respiratory, pain management, cancer, inflammation, neurology, and women's health, among others. It conducts research to develop biologics, biosimilars, vaccines and new chemical entities. The company has manufacturing facilities in Gujarat, Goa, Maharashtra, Sikkim and Himachal Pradeshin India; Brazil and the US. It has presence in the US, Europe, South Africa, Japan, Brazil, and other emerging markets. Zydus Cadila is headquartered in Ahmedabad, Gujarat, India.
Cadila Healthcare Ltd Key Recent Developments
Jun 07,2021: Serum Institute obtains DCGI nod to produce Sputnik V vaccine in India
May 31,2021: Zydus Cadila fights counterfeit drugs with new packaging feature
May 28,2021: Zydus Cadila files for DCGI approval to study Covid-19 drug in India
May 10,2021: Zydus Wellness’ consolidated Q4 Net Profit up by 92.7% at Rs. 1331 million
Feb 05,2021: Zydus Cadila’s Net Profit up by 41% in Q3 FY21
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Cadila Healthcare Ltd - Key Facts
Cadila Healthcare Ltd - Key Employees
Cadila Healthcare Ltd - Key Employee Biographies
Cadila Healthcare Ltd - Major Products and Services
Cadila Healthcare Ltd - History
Cadila Healthcare Ltd - Company Statement
Cadila Healthcare Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Company Overview
Cadila Healthcare Ltd - Business Description
Business Segment: Consumer Products
Overview
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: India
Performance
Geographical Segment: Others
Performance
Geographical Segment: The US
Performance
R&D Overview
Cadila Healthcare Ltd - Corporate Strategy
Cadila Healthcare Ltd - SWOT Analysis
SWOT Analysis - Overview
Cadila Healthcare Ltd - Strengths
Cadila Healthcare Ltd - Weaknesses
Cadila Healthcare Ltd - Opportunities
Cadila Healthcare Ltd - Threats
Cadila Healthcare Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cadila Healthcare Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jun 07, 2021: Serum Institute obtains DCGI nod to produce Sputnik V vaccine in India
May 31, 2021: Zydus Cadila fights counterfeit drugs with new packaging feature
May 28, 2021: Zydus Cadila files for DCGI approval to study Covid-19 drug in India
May 10, 2021: Zydus Wellness’ consolidated Q4 Net Profit up by 92.7% at Rs. 1331 million
Feb 05, 2021: Zydus Cadila’s Net Profit up by 41% in Q3 FY21
Feb 05, 2021: Re appointment of Mr. Apurva Diwanji for the second term of five consecutive years
Aug 05, 2020: Zydus Cadila’s Q1 net profit up by 50%
Jun 19, 2020: Cadila Healthcare : Appointment of Mr. Ganesh N. Nayak as the Whole Time Director of the Company
May 28, 2020: Cadila Healthcare formulation manufacturing facility receives EIR from the U.S. FDA
May 07, 2020: India’s CSIR proposes testing of sepsis treatment drug as Covid-19 vaccine
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Cadila Healthcare Ltd - Key Facts
Cadila Healthcare Ltd - Key Employees
Cadila Healthcare Ltd - Key Employee Biographies
Cadila Healthcare Ltd - Major Products and Services
Cadila Healthcare Ltd - History
Cadila Healthcare Ltd - Company Statement
Cadila Healthcare Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Company Overview
Cadila Healthcare Ltd - Business Description
Business Segment: Consumer Products
Overview
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: India
Performance
Geographical Segment: Others
Performance
Geographical Segment: The US
Performance
R&D Overview
Cadila Healthcare Ltd - Corporate Strategy
Cadila Healthcare Ltd - SWOT Analysis
SWOT Analysis - Overview
Cadila Healthcare Ltd - Strengths
Cadila Healthcare Ltd - Weaknesses
Cadila Healthcare Ltd - Opportunities
Cadila Healthcare Ltd - Threats
Cadila Healthcare Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cadila Healthcare Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jun 07, 2021: Serum Institute obtains DCGI nod to produce Sputnik V vaccine in India
May 31, 2021: Zydus Cadila fights counterfeit drugs with new packaging feature
May 28, 2021: Zydus Cadila files for DCGI approval to study Covid-19 drug in India
May 10, 2021: Zydus Wellness’ consolidated Q4 Net Profit up by 92.7% at Rs. 1331 million
Feb 05, 2021: Zydus Cadila’s Net Profit up by 41% in Q3 FY21
Feb 05, 2021: Re appointment of Mr. Apurva Diwanji for the second term of five consecutive years
Aug 05, 2020: Zydus Cadila’s Q1 net profit up by 50%
Jun 19, 2020: Cadila Healthcare : Appointment of Mr. Ganesh N. Nayak as the Whole Time Director of the Company
May 28, 2020: Cadila Healthcare formulation manufacturing facility receives EIR from the U.S. FDA
May 07, 2020: India’s CSIR proposes testing of sepsis treatment drug as Covid-19 vaccine
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Cadila Healthcare Ltd, Key Facts
Cadila Healthcare Ltd, Key Employees
Cadila Healthcare Ltd, Key Employee Biographies
Cadila Healthcare Ltd, Major Products and Services
Cadila Healthcare Ltd, History
Cadila Healthcare Ltd, Other Locations
Cadila Healthcare Ltd, Subsidiaries
Cadila Healthcare Ltd, Joint Venture
Cadila Healthcare Ltd, Key Competitors
Cadila Healthcare Ltd, Ratios based on current share price
Cadila Healthcare Ltd, Annual Ratios
Cadila Healthcare Ltd, Annual Ratios (Cont...1)
Cadila Healthcare Ltd, Annual Ratios (Cont...2)
Cadila Healthcare Ltd, Interim Ratios
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cadila Healthcare Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Cadila Healthcare Ltd, Key Facts
Cadila Healthcare Ltd, Key Employees
Cadila Healthcare Ltd, Key Employee Biographies
Cadila Healthcare Ltd, Major Products and Services
Cadila Healthcare Ltd, History
Cadila Healthcare Ltd, Other Locations
Cadila Healthcare Ltd, Subsidiaries
Cadila Healthcare Ltd, Joint Venture
Cadila Healthcare Ltd, Key Competitors
Cadila Healthcare Ltd, Ratios based on current share price
Cadila Healthcare Ltd, Annual Ratios
Cadila Healthcare Ltd, Annual Ratios (Cont...1)
Cadila Healthcare Ltd, Annual Ratios (Cont...2)
Cadila Healthcare Ltd, Interim Ratios
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cadila Healthcare Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Cadila Healthcare Ltd, Performance Chart (2017 - 2021)
Cadila Healthcare Ltd, Ratio Charts
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Cadila Healthcare Ltd, Performance Chart (2017 - 2021)
Cadila Healthcare Ltd, Ratio Charts
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021